GeneDx Holdings Corp.
WGS Healthcare Diagnostics & Research
GeneDx Holdings Corp.’s revenue for fiscal 2025 (year ended December 2025) was $427.5 million, up 40.0% from fiscal 2024.
- Revenue
- +11.4%
- EPS
- −257.9%
- Free cash flow
- −585.6%
- Total debt
- +87.4%
Quarter to June 2026, against a year earlier
Follow WGS
Alert me
GeneDx Holdings Corp. (WGS) Operating margin
GeneDx Holdings Corp.'s operating margin over the twelve months to 30 June 2026 was −20.3%, down 17.3 percentage points from fiscal 2025 (−3.06%). Over the past ten years it has ranged from −284.5% (fiscal 2022) to −3.06% (fiscal 2025) — the current reading is the highest in ten years. That is below the Diagnostics & Research industry median of −5.68% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −3.06% | 4.54 |
| FY2024 | −7.60% | 81.55 |
| FY2023 | −89.2% | 195.33 |
| FY2022 | −284.5% | (74.23) |
| FY2021 | −210.3% | (75.30) |
| FY2020 | −135.0% | (119.45) |
| FY2019 | −15.5% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −15.3% | 40.95 |
| Mar 2026 | −56.2% | (44.43) |
| Dec 2025 | −11.8% | (8.99) |
| Sep 2025 | −2.78% | (11.51) |
| 19 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| CDNA CareDx, Inc. compare | 23.4% |
| VCYT Veracyte, Inc. compare | 17.1% |
| FRNM Freenome, Inc compare | 0.00% |
| NEO NeoGenomics, Inc. compare | −6.27% |
| CSTL Castle Biosciences, Inc. compare | −7.43% |
| ADPT Adaptive Biotechnologies Corporation compare | −16.2% |
| WGS GeneDx Holdings Corp. | −20.3% |
| OPK OPKO Health, Inc. compare | −25.5% |
| PSNL Personalis, Inc. compare | −156.7% |
| Diagnostics & Research industry median | −5.68% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on WGS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement